Please wait a minute...
文章检索
预防医学  2018, Vol. 30 Issue (9): 884-888    DOI: 10.19485/j.cnki.issn2096-5087.2018.09.005
  论著 本期目录 | 过刊浏览 | 高级检索 |
UCA1表达水平及其启动子区域rs7255437单核苷酸多态性与结直肠癌的关系
李迎君1,刘冰2,景方圆1,丁烨1,何青芳3,钟要红1,范春红1
1.杭州医学院,浙江 杭州 310053;
2.杭州市疾病预防控制中心;
3.浙江省疾病预防控制中心
Association of UCA1 expression and rs7255437 polymorphism in UCA1 promoter region with colorectal cancer
LI Ying-jun*,LIU Bing,JING Fang-yuan,DING Ye,HE Qing-fang,ZHONG Yao-hong,FAN Chun-hong
*Hangzhou Medical College,Hangzhou,Zhejiang 310053,China
全文: PDF(582 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨长链非编码RNA尿路上皮癌胚抗原1(UCA1)表达水平及其启动子区域的单核苷酸多态性与结直肠癌发生发展的关系,为其作为结直肠癌风险的分子标志物提供依据。方法 分别纳入507例原发性结直肠癌患者和503例健康志愿者为病例组和对照组,采集血液检测UCA1 rs7255437位点单核苷酸多态性,分析UCA1 rs7255437多态性与结直肠癌发病的关联。采用生物信息学方法验证UCA1表达与rs7255437多态性及结直肠癌发病的关联。结果 与rs7255437 CC基因携带者相比,CT和TT基因型携带者发生结直肠癌的风险均升高,但差异均无统计学意义(P>0.05);与rs7255437 CC基因携带者相比,TT基因携带者发生晚期结直肠癌的风险降低67%(P<0.05)。生物信息学分析结果显示,在正常横结肠组织和小肠组织中,CT和TT基因携带者UCA1表达水平均高于CC基因携带者;结直肠癌晚期患者肠癌组织中UCA1表达水平高于结直肠癌早期患者(P<0.05)。结论 UCA1表达水平及其启动子区域rs7255437单核苷酸多态性作为结直肠癌风险的分子标志物具有一定潜力,但有待于基于自然人群的大样本前瞻性队列研究以及功能学研究进一步验证。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
李迎君,刘冰,景方圆,丁烨,何青芳,钟要红,范春红
关键词 长链非编码RNA尿路上皮癌胚抗原1结直肠癌单核苷酸多态性    
AbstractObjective To investigate the association of genetic variants in the promoter region of UCA1 and its expression level with colorectal cancer,especially to provide basis for UCA1 as a molecular biomarker for colorectal cancer risk. Methods Totally 507 cases of primary colorectal cancer and 503 healthy volunteers were included in the case group and the control group. The single nucleotide polymorphisms of the UCA1 rs7255437 locus were detected in the blood,and the association between the UCA1 rs7255437 polymorphism and the risk of colorectal cancer was analyzed. Bioinformatics method was used to verify the association between UCA1 expression and UCA1 rs7255437 polymorphism with risk of colorectal cancer. Results The results showed that compared with the CC genotype,CT and TT genotypes had an increased risk of colorectal cancer,however the difference was not statistically significant(P>0.05) . Compared with the CC genotype,TT genotype had a 67% decreased risk of advanced colorectal cancer(P<0.05) . The result of bioinformatics analysis showed that the UCA1 expression level of CT and TT carriers in normal transverse colon and small intestinal tissues was higher than that of CC carriers,and the expression level of UCA1 in colorectal cancer tissues in advanced colorectal cancer patients was higher than that of early colorectal cancer patients.Conclusion UCA1 expression and rs7255437 polymorphism are potential molecular markers for the development of colorectal cancer. However,confirmation studies with larger sample size and further mechanistic investigations into the function of UCA1 and its genetic variants are needed.
Key wordsLong non-coding RNAs    UCA1    Colorectal cancer    Single nucleotide polymorphism
          出版日期: 2018-09-04
中图分类号:  R732.34  
基金资助:国家自然科学基金(81703289);浙江省医药卫生科技计划项目(2017203626);浙江省公益性技术应用研究计划项目(2014C33224)
作者简介: 李迎君,博士,讲师,主要从事肿瘤分子流行病学研究工作
通信作者: 范春红,E-mail:340076899@qq.com   
引用本文:   
李迎君,刘冰,景方圆,丁烨,何青芳,钟要红,范春红. UCA1表达水平及其启动子区域rs7255437单核苷酸多态性与结直肠癌的关系[J]. 预防医学, 2018, 30(9): 884-888.
LI Ying-jun,LIU Bing,JING Fang-yuan,DING Ye,HE Qing-fang,ZHONG Yao-hong,FAN Chun-hong. Association of UCA1 expression and rs7255437 polymorphism in UCA1 promoter region with colorectal cancer. Preventive Medicine, 2018, 30(9): 884-888.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2018.09.005      或      https://www.zjyfyxzz.com/CN/Y2018/V30/I9/884
[1] TORRE L A,BRAY F,SIEGEL R L,et al. Global cancer statistics,2012[J] . CA Cancer J Clin,2015,65(2):87-108.
[2] CHEN W,ZHENG R,BAADE P D,et al. Cancer statistics in China,2015[J] . CA Cancer J Clin,2016,66(2):115-132.
[3] SIEGEL R L,MILLER K D,FEDEWA S A,et al. Colorectal cancer statistics,2017[J] . CA Cancer J Clin,2017,67(3):177-193.
[4] BROSNAN C A,VOINNET O. The long and the short of noncoding RNAs[J] . Curr Opin Cell Biol,2009,21(3):416-425.
[5] LEE J T. Epigenetic regulation by long noncoding RNAs[J] . Science,2012,338(6113):1435-1439.
[6] LI Y,BAO C,GU S,et al. Associations between novel genetic variants in the promoter region of MALAT1 and risk of colorectal cancer[J] . Oncotarget,2017,8(54):92604-92614.
[7] WANG X S,ZHANG Z,WANG H C,et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma[J] . Clin Cancer Res,2006,12(16):4851- 4858.
[8] HAN Y,YANG Y N,YUAN H H,et al. UCA1,a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation,apoptosis and cell cycle distribution[J] . Pathology,2014,46(5):396-401.
[9] JIN M,GU S,YE D,et al. Association between genetic variants in the promoter region of a novel antisense long noncoding RNA RP11-392P7.6 and colorectal cancer risk[J] . Environ Mol Mutagen, 2017,58(6):434-442.
[10] LING H,SPIZZO R,ATLASI Y,et al. CCAT2,a novel noncoding RNA mapping to 8q24,underlies metastatic progression and chromosomal instability in colon cancer[J] . Genome Res,2013, 23(9):1446-1461.
[11] GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis:multitissue gene regulation in humans[J] . Science,2015,348 (6235):648-660.
[12] 张晓怡,沈毅,韩雅斌,等. 桐乡市常见恶性肿瘤危险因素分析[J] . 浙江预防医学,2014,26(2):150-153.
[13] RIM S H,SEEFF L,AHMED F,et al. Colorectal cancer incidence in the United States,1999-2004 :an updated analysis of data from the National Program of Cancer Registries and the Surveillance,Epidemiology,and End Results Program[J] . Cancer,2009,115(9):1967-1976.
[14] DE VOOGHT K M,VAN WIJK R,VAN SOLINGE W W. Management of gene promoter mutations in molecular diagnostics[J] . Clin Chem,2009,55(4):698-708.
[15] WANG Y H,WANG F,ZHANG L,et al. Long non-coding RNA UCA1 can predict tumor lymph node metastasis[J] . Tumour Biol,2017,39(5):1010428317706208.
[16] BIAN Z,JIN L,ZHANG J,et al. LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p[J] . Sci Rep,2016(6):23892.
[17] NI B,YU X,GUO X,et al. Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer[J] . Int J Oncol,2015,47(4):1329-1338.
[1] 周凡, 王小红, 陈梦倩, 张小兰, 徐则林. 2016—2027年金华市结直肠癌发病和死亡趋势分析及预测[J]. 预防医学, 2026, 38(1): 26-30.
[2] 李玉荣, 王冬飞, 高媛媛, 蒋园园, 林君英, 肖段段. 2010—2024年萧山区结直肠癌发病趋势分析[J]. 预防医学, 2025, 37(9): 927-931,936.
[3] 张闻烙, 朱琳, 王岩, 刘广超, 王文翔, 蔡迎彬. NFKB1LHX2基因多态性与食管癌易感性研究[J]. 预防医学, 2025, 37(4): 350-355.
[4] 张莹, 陈伊绚, 高玥, 王晔, 李剑森, 韩毓桐, 魏文强, 廖羽. 2020年广东省肿瘤登记地区结直肠癌流行特征分析[J]. 预防医学, 2025, 37(10): 997-1001.
[5] 陈铭睿, 林玲, 楚楚, 黄捷, 韩亚蓉, 蔡波, 韩颖颖. 2013—2022年南通市结直肠癌发病和死亡趋势分析[J]. 预防医学, 2025, 37(10): 1039-1044.
[6] 顾思萌, 李雅晖, 王晓峰, 莫哲. MAGI2-AS3在肿瘤发生发展中的调控机制研究进展[J]. 预防医学, 2024, 36(7): 594-597.
[7] 蒋鸣孝, 李剑, 黄旭云. 上城区结直肠癌筛查结果分析[J]. 预防医学, 2024, 36(6): 501-505.
[8] 和金金, 朱陈, 潘婷婷, 黄文雯, 蒋秉洁, 余炜燕, 王乐, 吴维妙, 杭栋, 杜灵彬. 定性和定量粪便免疫化学试验筛查结直肠癌效果评价[J]. 预防医学, 2024, 36(4): 317-321.
[9] 陈淑淑, 龚巍巍, 关云琦, 周晓燕, 潘劲, 戴品远, 王浩, 李娜, 俞敏. 1990—2019年浙江省结直肠癌疾病负担和危险因素分析[J]. 预防医学, 2024, 36(3): 203-206.
[10] 高菡璐, 俞晓芳, 吕乐彬, 叶国良, 樊金卿. 多靶点粪便DNA、肠道菌群、癌胚抗原及水果摄入对结直肠癌风险的交互作用研究[J]. 预防医学, 2024, 36(3): 219-223.
[11] 高可润, 禹顺英, 李华芳. 精神分裂症患者PTEN基因多态性与利培酮疗效及锥体外系症状的关联研究[J]. 预防医学, 2024, 36(12): 1060-1064.
[12] 沈方力, 茅俭英, 孟杨, 朱礼明, 柏红, 汤德珍, 刘世友. 宝山区居民结直肠癌筛查结果分析[J]. 预防医学, 2024, 36(10): 869-872,877.
[13] 曾龙武, 唐晓鸿, 张素霞, 刘强, 梁朝聪, 唐漫漫. 结直肠癌化疗患者照护人疾病不确定感影响因素分析[J]. 预防医学, 2023, 35(5): 444-447.
[14] 吕乐彬, 樊金卿, 赵王芳, 陆启文, 顾俊娣, 高菡璐. 肠镜检查人群多靶点粪便DNA检测意愿的影响因素分析[J]. 预防医学, 2023, 35(3): 218-223.
[15] 靳明英, 沈蔚, 陈俊斐, 冯玲芳, 应士波, 夏海玲, 陈钧强, 陈祎秋, 蒋兆强, 楼建林. 长链非编码RNA JPX诊断间皮瘤及预后的价值研究[J]. 预防医学, 2023, 35(3): 235-238,242.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed